Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities

Diabetes

Volumn 47, Issue 4, 1998, Pages 660-667

  Ferri, Claudio ^a   Desideri, Giovambattista ^a   Baldoncini, Roberta ^a   Bellini, Cesare ^b   De Angelis, Claudio ^a   Mazzocchi, Clarita ^c   Santucci, Anna ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HYDROCHLOROTHIAZIDE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LOSARTAN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERLIPIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; E-SELECTIN; ENALAPRIL; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; MALE; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 0031923033     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.4.660     Document Type: Article

References (23)

1. Bevilacqua MP, Nelson RM: Selectins. J Clin Invest 91:379-387, 1993
2. Dustin ML, Staunton DE, Springer TA: Supergene families meet the immune system. Immunol Today 9:213-215, 1988
3. Lang Y, Lincoff M, Plow EF, Topol EJ: Cell adhesion molecules in coronary heart disease. J Am Coll Cardiol 24:1591-1601, 1994
4. Frenette PN, Wagner DD: Adhesion molecules. Part II. Blood vessels and blood cells. N Eng J Med 335:43-45, 1996
5. Gearing AJH, Hemingway I, Pigott R, Highes J, Rees AJ, Cashman SJ: Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 667:324-331, 1992
6. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD: Increased levels of soluble adhesion molecules in type 2 (non-insulin-dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979-984, 1994
7. Fasching P, Waldhausl W, Wagner OF: Elevated circulating adhesion molecules in NIDDM: potential mediators in diabetic macroangiopathy. Diabetologia 39:1242-1244, 1996
8. Blann AD, Tse W, Maxwell SJR, Waite MA: Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 12:925-928, 1994
9. Stehouwer CDA, Fischer HR, van Kuijk AWR, Polak BCP, Donker AJM: Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44:431-436, 1995
10. Ferri C, Bellini C, Desideri G, De Mattia G, Santucci A: Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care 19:504-506, 1996
11. Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, De Mattia G: Plasma endothelin-1 in obese hypertensive and normotensive men. Diabetes 44:431-436, 1995
12. Ferri C, Bellini C, Desideri G, Baldoncini R, De Siati L, Santucci A: Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalities. Diabetologia 40:100-102, 1997
13. Reaven GM: Banting Lecture: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
14. Drexler H, Kurz S, Jeserich M, Munzel T, Hornig B: Effect of chronic angiotensin-converting-enzyme inhibition on endothelial function in patients with chronic heart failure. Am J Cardiol 15,76:13E-18E, 1995
15. Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Gonano F, Bartoli E: Increased circulating levels of ICAM-1 in type 2 diabetic patients: the role of oxidative stress and metabolic control (Abstract). Diabetologia 38 (Suppl. 1):A41, 1995
16. American Diabetes Association: Screening for diabetes (Position Statement). Diabetes Care 12:588-589, 1989
17. Friedewald WT, Levy R, Frederickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
18. Gearing AJH, Newman W: Circulating adhesion molecules in disease. Immunol Today 14:506-512, 1993
19. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti M, Moghetti P, Lo Cascio V: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38:1122-1124, 1995
20. Hadcocks S, Richardson M, Winocour P, Hatton MWC: Intimal alterations in the first six months of alloxan-induced diabetes. Arterioscl Tromb 11:517-529, 1991
21. Kim JA, Berliner JA, Nataryan RD, Nadler JL: Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 9:1103-1107, 1994
22. Timmermans PBMWM, Wong PC, Chin AT, Herblin WF, Benfied P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD: Angiotensin II receptors and angiotensin II receptors antagonist. Pharm Rev 46:205-225, 1993
23. Krejcy K, Eichler HG, Silena B, Kapiotis J, Woltz M, Zanoschka G, Geric S, Wagner O: Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo. Can J Physiol Pharmacol 74:9-14, 1996